New Nanocarriers Study Findings Have Been Reported from Minia University [Beryllium Oxide (Be 12 O 12) As a Nanocarrier for Cisplatin Anticancer Drug and Some of Its Analogs: a Dft Investigation].

MLA

“New Nanocarriers Study Findings Have Been Reported from Minia University [Beryllium Oxide (Be 12 O 12) As a Nanocarrier for Cisplatin Anticancer Drug and Some of Its Analogs: A Dft Investigation].” Cancer Weekly, Nov. 2024, p. 739. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=180743593&authtype=sso&custid=ns315887.

APA

New Nanocarriers Study Findings Have Been Reported from Minia University [Beryllium Oxide (Be 12 O 12) As a Nanocarrier for Cisplatin Anticancer Drug and Some of Its Analogs: a Dft Investigation]. (2024). Cancer Weekly, 739.

Chicago

“New Nanocarriers Study Findings Have Been Reported from Minia University [Beryllium Oxide (Be 12 O 12) As a Nanocarrier for Cisplatin Anticancer Drug and Some of Its Analogs: A Dft Investigation].” 2024. Cancer Weekly, November, 739. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=180743593&authtype=sso&custid=ns315887.